UNASSIGNED: Although about 80% of @entity1 with @entity50 have a good prognosis, some @entity1 develop severe complications and small proportions do not survive. The study included @entity1 who had been diagnosed with @entity50 in our hospital from May 2008 to February 2014. Based on the @entity2653 ( @entity2653 ) scores at 3 months for outcome, the @entity1 were divided into two groups: good prognosis ( @entity2653 score  <= 2) and poor prognosis ( @entity2653 score > 2). Univariate and multivariate regression analysis were performed to identify significant prognostic factors for poor outcome. A total of 86 @entity1 with @entity50 , 54 males and 32 females, average age 41.3 years (range, 3-83 years), were enrolled. Of these 86 @entity1 , 64 (74.4%) had a good prognosis and 22 (25.6%) a poor prognosis. Univariate analysis revealed that @entity910 was a significant risk factor (factor with odds ratio >1) for poor prognosis. In multivariate analysis, the risk of poor prognosis in @entity1 with @entity910 was 23 times higher than for those without @entity910 (p < 0.001). @entity715 of the sinus transervus was found to reduce the risk of poor prognosis in both univariate and multivariate analysis. Most @entity1 with @entity50 have a good prognosis but @entity1 with @entity910 have a poorer prognosis.

Poor prognostic outcome in @entity50 associated with XXXX and elevated platelet volume.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity2653 :: ('MESH:C538175', 'Disease') :: ['mRS', 'modified Rankin Scale'] @entity910 :: ('MESH:D004409', 'Disease') :: ['dyskinesia'] @entity715 :: ('MESH:D013927', 'Disease') :: ['Thrombosis'] @entity50 :: ('MESH:D012851', 'Disease') :: ['cerebral venous sinus thrombosis']
@entity910 :: (MESH:D004409,Disease) :: ['dyskinesia']
